PLEKHM1P expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.63180580159406E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.98370011925431E-10 |
Normal-vs-Stage2 |
1.607460E-04 |
Normal-vs-Stage3 |
9.44079999731784E-08 |
Normal-vs-Stage4 |
6.08309999999834E-05 |
Stage1-vs-Stage2 |
3.732800E-01 |
Stage1-vs-Stage3 |
4.467800E-01 |
Stage1-vs-Stage4 |
7.355200E-01 |
Stage2-vs-Stage3 |
7.758400E-01 |
Stage2-vs-Stage4 |
6.335600E-01 |
Stage3-vs-Stage4 |
7.845000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.55968596213552E-12 |
Normal-vs-AfricanAmerican |
1.08180000002456E-06 |
Normal-vs-Asian |
1.904410E-03 |
Caucasian-vs-AfricanAmerican |
2.081700E-02 |
Caucasian-vs-Asian |
9.922500E-03 |
AfricanAmerican-vs-Asian |
2.383000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.29019955514332E-10 |
Normal-vs-Female |
1.41997524849558E-13 |
Male-vs-Female |
2.607500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.341900E-02 |
Normal-vs-Age(41-60Yrs) |
5.45674616603264E-13 |
Normal-vs-Age(61-80Yrs) |
1.40510000301575E-08 |
Normal-vs-Age(81-100Yrs) |
1.048310E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.668000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.248400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.829000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.215620E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.237600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.600400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.67840000015107E-07 |
Normal-vs-Grade 2 |
1.12940001795181E-09 |
Normal-vs-Grade 3 |
1.70710001690111E-09 |
Normal-vs-Grade 4 |
2.352800E-04 |
Grade 1-vs-Grade 2 |
1.846010E-04 |
Grade 1-vs-Grade 3 |
1.626580E-04 |
Grade 1-vs-Grade 4 |
1.212470E-04 |
Grade 2-vs-Grade 3 |
8.702400E-01 |
Grade 2-vs-Grade 4 |
6.505600E-01 |
Grade 3-vs-Grade 4 |
7.232400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.40760003652929E-09 |
Normal-vs-ccB subtype |
7.22929999974475E-07 |
ccA subtype-vs-ccB subtype |
5.908400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.61990421077007E-11 |
Normal-vs-N1 |
5.657800E-02 |
N0-vs-N1 |
6.929000E-01 |
|
|